Using eye drops in compliance may improve the symptoms and quality of life in patients with seasonal allergic conjunctivitis: analysis of a two-season web survey

作     者：Asako Kodama Dogru Murat Hiroshi Fujishima Kazumi Fukagawa 

作者机构：Department of OphthalmologyEiju General HospitalTokyo 110-8645Japan Department of OphthalmologyTsurumi University School of Dental MedicineKanagawa 230-0063Japan Ryogoku Eye ClinicTokyo 130-0062Japan 

出 版 物：《International Journal of Ophthalmology(English edition)》 (国际眼科杂志（英文版）)

年 卷 期：2023年第16卷第6期

页      面：988-991页

核心收录：

学科分类：1002[医学-临床医学] 100213[医学-耳鼻咽喉科学] 10[医学] 

主　　题：allergic patients seasonal 

摘      要：Dear Editor,Allergic conjunctivitis is the most common ocular surface allergic disease, affecting more than 30% of the population[1-2]. In the immediate phase of the allergic reactions(type Ⅰ) in patients with seasonal allergic conjunctivitis(SAC), the binding of antigen with the reaginic antibody leads to the formation and release of chemical mediators, such as histamines, in the local anaphylactic reaction[3].